Two Case Reports of Life-Threatening Croup Caused by the SARS-CoV-2 Omicron BA.2 Variant in Pediatric Patients

J Korean Med Sci. 2022 Jun 20;37(24):e192. doi: 10.3346/jkms.2022.37.e192.

Abstract

Croup is a common upper airway infection characterized by a barking cough, stridor, and hoarseness. It is usually caused by viral infection. A small number of croup caused by coronavirus disease 2019 (COVID-19) has been reported in children before the omicron variant surge. Previously reported cases indicated that croup caused by COVID-19 can be treated in the same manner as those with other viral causes. We describe two cases (9-month-old girl and 11-month-old boy) of previously healthy infants who presented with a barking cough and chest retraction and required endotracheal intubation and cardiopulmonary resuscitation. Despite receiving dexamethasone and nebulized racemic epinephrine (NRE) treatment for croup in the emergency department, these patients still developed acute respiratory failure. Reverse transcription polymerase chain reaction (RT-PCR) of nasopharyngeal samples revealed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron BA.2 variant (Stealth omicron) and no other common respiratory viral pathogens. Both patients were treated with mechanical ventilation, dexamethasone, and NRE in the pediatric intensive care unit. The duration of intubation was 112 hours and 80 hours, respectively. Both patients were discharged without complications. To the best of our knowledge, this is the first report of life-threatening croup produced by the omicron BA.2 variant and confirmed by RT-PCR. We suggest that this SARS-CoV-2 variant may cause severe croup that may not improve with conventional treatment, even in children without underlying diseases.

Keywords: Cardiopulmonary Resuscitation (CPR); Coronavirus Disease 2019 (COVID-19); Croup; SARS-CoV-2; Severe Croup.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 Drug Treatment*
  • Child
  • Cough
  • Croup* / diagnosis
  • Croup* / drug therapy
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Infant
  • Male
  • Racepinephrine*
  • SARS-CoV-2

Substances

  • Dexamethasone
  • Racepinephrine

Supplementary concepts

  • SARS-CoV-2 variants